• Consultant: Life Science Vendors Need a New Game Plan

    Oct 15 | eCliniqua | Life science vendors must become more strategic and price-sensitive to “stay in the game” with their clients in the trillion-dollar drug development industry, says Andreas Scherer, managing partner at consulting firm Salto Partners. The industry consensus is that drug research takes too long and has grown unsustainably expensive.

    Oct 15, 2012

  • WCC Announces Endpoint Assessment Committee

    Oct 1 | News Brief | WorldCare Clinical (WCC) has announced its new Endpoint Assessment Committee (EAC) services for blinded independent central review of clinical trial data. WCC’s EAC services include expert assessments by physicians drawn from multiple therapeutic areas for comprehensive efficacy and safety reviews.

    Oct 1, 2012

  • Medidata Uses Open Chef for Clinical Development in the Cloud

    Sep 24 | eCliniqua | Medidata Solutions has deployed Opscode Hosted Chef to automate its hybrid infrastructure for clinical development: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, to clinical data capture and management, safety events capture, medical coding, and business analytics. 

    Sep 24, 2012

  • Sanofi Uses BioClinica's CTMS

    Sep 24 | News Brief | Sanofi has selected BioClinica's OnPoint as the company's standard CTMS (Clinical Trial Management System). With this decision, Sanofi plans to utilize OnPoint CTMS for all clinical trial management activity. 

    Sep 24, 2012

  • Phase II Flub for Peregrine

    Sep 24 | Cancer Grace | A week after releasing favorable Phase II results for the novel vascular-targeting immunotherapy for non-small cell lung cancer, bavituximab, study sponsor Peregrine Pharmaceuticals has announced "major discrepancies" in the trial.

    Sep 24, 2012

  • Why You Should Be Adopting Adaptive Trials

    Sep 20 | eCliniqua | A special one-day conference next month will showcase many of the leading figures in the emerging field of adaptive trial designs, with a view to helping organizations recognize their benefits and understand the keys to successful implementation.

    Sep 20, 2012

  • Updated EDC for Any Research Initiative

    Sep 17 | Product Brief | The latest version of iMedNet EDC was announced today. iMedNet EDC makes electronic data capture functionality practical for any type of research initiative, even very small studies of short duration. 

    Sep 17, 2012

  • Mathieu Takeaways on the 2012 Clinical Trial Sourcebook

    Sep 17 | eCliniqua | Mark Mathieu—director of Strategic Research at PAREXEL Consulting—is the founding editor of the PAREXEL Biopharmaceutical R&D Statistical Sourcebook. As such, he is the ideal person to discuss the highlights and nuances that emerge in the latest edition of the sourcebook (2012-13). Mathieu recently spoke to Barnett International’s Rachel Meyers.

    Sep 12, 2012

  • Boehringer Ingelheim to Launch Pharma Facebook Game

    PSFK | Boehringer Ingelheim has developed a Facebook game called Syrum. The health of the world is in the user's hands, and players can collaborate with others to save it. 

    Sep 13, 2012

  • Isis Tightens Bond to BioClinica

    Sep 13 | eCliniqua Exclusive | EDC purist Isis Pharmaceuticals is stepping up its partnering activity with BioClinica, Inc. to include larger and more complex clinical trials within its expansive antisense drug development program. Up to 20 new trials are on the docket for next year, including several phase III studies involving thousands of participants.  

    Sep 12, 2012

  • CDISC and C-Path Launch Coalition for Accelerating Standards Therapies

    Sep 12 | CDISC | The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) have announced the launch of the Coalition For Accelerating Standards and Therapies (CFAST), a follow-up to the partnership agreement signed earlier this year.

    Sep 12, 2012

  • Informed Consent: There's an App for That

    Sept 12 | PharmaTimes | Mytrus has launched an iPad app explaining the informed consent process.

    Sep 12, 2012

  • Are You Ready for Vendor Oversight Scrutiny?

    Sep 11 | Guest Commentary | Regulators are paying increased attention to sponsors within the realm of vendor oversight. Clinical Trial Sponsors must include vendor oversight in any assessment of inspection readiness on their mid-stage development programs, and once the gaps have been identified, apply preventative actions across all outsourced programs in development.  

    Sep 10, 2012

  • Department of Health and Human Services Launches Trial Research with Medidata Databases

    Sep 10 | eCliniqua | The U.S. Department of Health and Human Services (HHS) has chosen Medidata’s trial cost benchmark data to support research into current cost data for clinical trials.  

    Sep 10, 2012

  • NextDocs Launches Trial Exchange

    Sep 10 | Product Brief |​ NextDocs Corporation has launched Trial Exchange, a simple, consumer-style interface for investigators and site staff to access and contribute essential documents for clinical trials. 

    Sep 10, 2012

  • PHT Corporation Announces NetPRO 1.3 for Patient Data Capture

    Sep 7 | eCliniqua | PHT Corporation has released NetPRO 1.3, the latest version of its web-based system for collecting patient and clinician data for clinical trials and post-marketing studies. 

    Sep 7, 2012

  • Technology to Replace Doctors?

    Sep 6 | VB | Vinod Khosla, co-founder of Sun Microsytems, says technology will replace 80% of doctors.

    Sep 6, 2012

  • More Choice in British Clinical IT Systems

    Sep 5 | Onmedica | IT supplier CSC has lost its exclusive rights to be the only provider of clinical IT systems in the North, Midlands and East of England.

    Sep 5, 2012

  • GUEST COMMENTARY: Can Outsourcing Reach Its Full Potential?

    Aug 29 | eCliniqua | GUEST COMMENTARY | Faced with a looming patent cliff, supply-chain issues and dwindling pipelines, Big Pharma has to take a closer look at outsourcing as a way to bolster development and manufacturing strategies. Electing for a leaner approach makes sense for many reasons but several key concerns must be addressed, ranging from innovation to emerging markets.  

     

    Aug 29, 2012

  • 211 Deaths in Six Months During Clinical Trials in India

    Aug 20 | Times of India | Investigators are probing why as many as 211 people have died in India in the first half of 2012 due to serious adverse events during clinical trials.

    Aug 18, 2012